I help bring new cancer and rare disease treatments to patients, guiding projects from early research all the way through clinical trials. Over the years, I’ve worked with a range of therapies – from small molecules and drug‐device combos to CAR-T/TCR-T cells, viral vector-based gene therapies, oncolytic viruses, antibodies, ADCs, and intratumoral delivery. I’ve led […]
I am a 12x founder of life sciences technology startups, having raised over $30 million across my portfolio, with both successful exits and ongoing ventures. My companies have spanned biotechnology, software, medical devices, cosmeceuticals, gene therapy, and a venture studio investment platform. My expertise lies in technology commercialization — bringing innovative products from concept to […]
I am the Clinical Chief of the Hematopathology Division, and a physician-scientist at Weill Cornell, where I combine my clinical and research skills to advance the understanding and diagnosis of hematological malignancies. I am actively involved in patient care through hematopathology diagnostics. For several years, I also directed the Multiparametric In Situ Imaging (MISI) Laboratory, […]
Healthcare executive and scientist with 25+ years of leadership in biotechnology, focused on turning scientific innovation into commercial and clinical impact. Proven track record advancing first-in-class therapies and diagnostics, securing FDA clearances, and driving growth across public and private companies—including generating $10M+ in oncology revenue, expanding diagnostic portfolios, and managing a $30M P&L. Currently Chief […]
Physician-scientist and biotechnology professional with extensive expertise in clinical development, medical affairs, and real-world evidence across oncology, hematology, and cardiovascular medicine. Trained in medicine, epidemiology, biostatistics, and health economics, with experience bridging academic research and the life sciences industry. Adept at translating complex clinical and population-level data into actionable insights that drive therapeutic and medical […]
I have over 30 years of experience in small molecule and biologic drug discovery and development across Europe and the USA, with extensive expertise in regulatory filings and project management within both biotech and large pharmaceutical companies. I believe in empowering teams to focus on their strengths without distraction, a leadership approach that has made […]
I am a Board Director at Novocure and a physician-scientist focused on oncology innovation, clinical development strategy, and translational medicine. As Professor of Clinical Medicine at Weill Cornell Medicine, I bring over two decades of leadership in precision oncology and clinical research. I help life sciences organizations translate scientific breakthroughs into clinically meaningful therapies by […]
With over 20 years of experience spanning emergency medicine, healthcare innovation, and AI strategy, I support healthcare organizations in adopting artificial intelligence safely and effectively. My focus is helping leaders move from AI interest to practical implementation with clear guardrails around clinical value, patient safety, and governance. I work at the intersection of medicine and […]
With over 16 years of experience in cell biology, oncology drug discovery, and translational science, I support biotech and pharma teams in moving programs from early discovery toward preclinical readiness. My work focuses on building robust screening and validation strategies that improve decision quality before costly downstream development. I have led teams across major organizations […]